Cipla’s arm enters into agreement to sell 100% stake in Cipla Croatia

01 Dec 2017 Evaluate

Cipla’s subsidiary - Cipla Holding B.V., has entered into an agreement to sell its 100% equity stake in Cipla Croatia d.o.o., Croatia to PharmaS d.o.o., Croatia in order to align with company’s strategy to operate via a B2B model in Europe. The transaction is expected to be closed within 45 days from Effective Date i.e. November 30, 2017.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.


Cipla Share Price

1326.00 13.35 (1.02%)
05-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1313.05
Cipla 1326.00
Zydus Lifesciences 914.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×